SUMOylation inhibitors activate anti-tumor immunity by reshaping the immune microenvironment in a preclinical model of hepatocellular carcinoma

被引:0
|
作者
Zengbin Wang
Banglun Pan
Lili Su
Huahui Yu
Xiaoxuan Wu
Yuxin Yao
Xiaoxia Zhang
Jiacheng Qiu
Nanhong Tang
机构
[1] Fujian Medical University,Department of Immunology, School of Basic Medical Sciences
[2] Fujian Medical University Union Hospital,Department of Hepatobiliary Surgery and Fujian Institute of Hepatobiliary Surgery
[3] Cancer Center of Fujian Medical University,undefined
[4] Fujian Medical University Union Hospital,undefined
[5] Key Laboratory of Gastrointestinal Cancer (Fujian Medical University),undefined
[6] Ministry of Education,undefined
来源
Cellular Oncology | 2024年 / 47卷
关键词
SUMOylation inhibitors; Intestinal microbiota; Immune microenvironment; Hepatocellular carcinoma;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:513 / 532
页数:19
相关论文
共 50 条
  • [31] The tyrosine kinase inhibitor XL092 promotes an immune-permissive tumor microenvironment and enhances the anti-tumor activity of immune checkpoint inhibitors in preclinical models
    Hsu, Jeff
    Chong, Colin
    Serrill, Jeffrey
    Wu, Sharon
    Leong, Kevin
    Yun, Ted
    Bannen, Lynne
    Lamb, Peter
    Xu, Wei
    Yu, Peiwen
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12)
  • [32] LYSOSOMAL AUTOPHAGY-BASED DEGRADATION OF HEPATOCELLULAR CARCINOMA PD-L1 MODULATES TUMOR MACROPHAGE POLARIZATION TO ACTIVATE ANTI-TUMOR IMMUNITY
    Gao, Xu
    He, Wangxiao
    Xie, Enrui
    Xing, Zixuan
    Zhang, Yue
    Wang, Jinhai
    Yan, Jin
    Ji, Fanpu
    HEPATOLOGY, 2024, 80 : S2009 - S2010
  • [33] Glutaryl-CoA dehydrogenase suppresses tumor progression and shapes an anti-tumor microenvironment in hepatocellular carcinoma
    Lao, Yuanxiang
    Cui, Xiaohan
    Xu, Zhu
    Yan, Hongyao
    Zhang, Zechuan
    Zhang, Zhenwei
    Geng, Longpo
    Li, Binghua
    Lu, Yijun
    Guan, Qifei
    Pu, Xiaohong
    Zhao, Suwen
    Zhu, Jiapeng
    Qin, Xihu
    Sun, Beicheng
    JOURNAL OF HEPATOLOGY, 2024, 81 (05)
  • [34] Estrogen/ER in anti-tumor immunity regulation to tumor cell and tumor microenvironment
    Wang, Tiecheng
    Jin, Jiakang
    Qian, Chao
    Lou, Jianan
    Lin, Jinti
    Xu, Ankai
    Xia, Kaishun
    Jin, Libin
    Liu, Bing
    Tao, Huimin
    Yang, Zhengming
    Yu, Wei
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [35] Anti-tumor immunity and tumor anti-immunity in a mathematical model of tumor immunotherapy
    Forys, U
    Waniewski, J
    Zhivkov, P
    JOURNAL OF BIOLOGICAL SYSTEMS, 2006, 14 (01) : 13 - 30
  • [36] Estrogen/ER in anti-tumor immunity regulation to tumor cell and tumor microenvironment
    Tiecheng Wang
    Jiakang Jin
    Chao Qian
    Jianan Lou
    Jinti Lin
    Ankai Xu
    Kaishun Xia
    Libin Jin
    Bing Liu
    Huimin Tao
    Zhengming Yang
    Wei Yu
    Cancer Cell International, 21
  • [37] Impact of calorie restriction on anti-tumor immune responses in the preclinical cancer model
    Nguyen, Dung T.
    CANCER SCIENCE, 2023, 114 : 1414 - 1414
  • [38] OMX IS A TUMOR MICROENVIRONMENT MODIFIER THAT RESTORES ANTI-TUMOR IMMUNITY AND IMPROVES ANTI-TUMOR EFFICACY BY REDUCING TUMOR HYPOXIA IN INTRACRANIAL GLIOBLASTOMA MOUSE MODEL
    Le Moan, Natacha
    Davis, Tina
    Leung, Philberta
    Ng, Sarah
    Winger, Jonathan
    Cary, Stephen
    Butowski, Nicholas
    Krtolica, Ana
    NEURO-ONCOLOGY, 2018, 20 : 259 - 259
  • [39] Hyperdifferentiated murine melanoma cells promote adaptive anti-tumor immunity but activate the immune checkpoint system
    Ando, Yukie
    Horiuchi, Yutaka
    Hatazawa, Sara
    Mataki, Momo
    Nakamura, Akihiro
    Murakami, Takashi
    ONCOIMMUNOLOGY, 2025, 14 (01):
  • [40] Osthole promotes anti-tumor immune responses in tumor-bearing mice with hepatocellular carcinoma
    Zhang, Lurong
    Jiang, Guorong
    Yao, Fei
    Liang, Guoqiang
    Wang, Fei
    Xu, Heng
    Wu, Yan
    Yu, Xiao
    Liu, Haiyan
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2015, 37 (03) : 301 - 307